-
STRO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Sutro Biopharma (STRO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 175.44 mm | 175.44 mm | 175.44 mm | 175.44 mm | 175.44 mm | 175.44 mm |
Cash burn (monthly) | (no burn) | (no burn) | 22.64 mm | 10.66 mm | 21.51 mm | 8.81 mm |
Cash used (since last report) | n/a | n/a | 96.42 mm | 45.41 mm | 91.59 mm | 37.53 mm |
Cash remaining | n/a | n/a | 79.01 mm | 130.03 mm | 83.84 mm | 137.91 mm |
Runway (months of cash) | n/a | n/a | 3.5 | 12.2 | 3.9 | 15.7 |
13F holders | Current |
---|---|
Total holders | 135 |
Opened positions | 25 |
Closed positions | 14 |
Increased positions | 50 |
Reduced positions | 32 |
13F shares | Current |
---|---|
Total value | 209.53 bn |
Total shares | 71.45 mm |
Total puts | 31.40 k |
Total calls | 77.10 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Suvretta Capital Management | 7.19 mm | $24.87 bn |
BlackRock | 7.02 mm | $24.28 bn |
Vanguard | 4.20 mm | $14.51 bn |
Point72 Asset Management | 3.00 mm | $10.37 bn |
MPM Oncology Impact Management | 2.83 mm | $9.80 bn |
Adage Capital Partners GP, L.L.C. | 2.25 mm | $7.79 bn |
Adage Capital Management | 2.25 mm | $8.01 mm |
Samsara BioCapital | 2.20 mm | $7.60 bn |
Citadel Advisors | 2.13 mm | $7.36 bn |
Kynam Capital Management | 2.07 mm | $7.15 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Dec 24 | Jane Chung | Common Stock | Payment of exercise | Dispose F | No | No | 2.69 | 8,920 | 23.99 k | 70,342 |
1 Dec 24 | Jane Chung | Common Stock | Option exercise | Acquire M | No | No | 0 | 25,000 | 0.00 | 79,262 |
1 Dec 24 | Jane Chung | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 25,000 | 0.00 | 75,000 |
18 Sep 24 | Hans-Peter Gerber | Common Stock | Payment of exercise | Dispose F | No | No | 3.95 | 13,380 | 52.85 k | 24,120 |
18 Sep 24 | Hans-Peter Gerber | Common Stock | Option exercise | Acquire M | No | No | 0 | 37,500 | 0.00 | 37,500 |
18 Sep 24 | Hans-Peter Gerber | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 37,500 | 0.00 | 112,500 |
9 Aug 24 | Jane Chung | Common Stock | Payment of exercise | Dispose F | No | No | 3.12 | 6,689 | 20.87 k | 54,262 |
9 Aug 24 | Jane Chung | Common Stock | Option exercise | Acquire M | No | No | 0 | 18,750 | 0.00 | 60,951 |
9 Aug 24 | Jane Chung | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 18,750 | 0.00 | 18,750 |
8 Aug 24 | Sukhi Jagpal | Stock Option Common Stock | Grant | Acquire A | No | No | 3.22 | 28,959 | 93.25 k | 28,959 |